SCHEMBL6055907

SCHEMBL6055907

C=[N+](c1cc(C)c(O)c(C)c1)c1c(SC(F)(F)F)c(C#N)nn1-c1c(Cl)cc(C(F)(F)F)cc1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRB3 P28472 19/20 0.43
GABRA2 P47869 17/20 0.43
GABRB2 P47870 17/20 0.43
GABRP O00591 15/20 0.43
GABRD O14764 15/20 0.43
GABRA1 P14867 15/20 0.43
GABRB1 P18505 15/20 0.43
GABRG2 P18507 15/20 0.43
GABRA5 P31644 15/20 0.43
GABRA3 P34903 15/20 0.43
GABRA4 P48169 15/20 0.43
GABRE P78334 15/20 0.43
GABRA6 Q16445 15/20 0.43
GABRG1 Q8N1C3 15/20 0.43
GABRG3 Q99928 15/20 0.43
GABRQ Q9UN88 15/20 0.43
NR1I2 O75469 1/20 0.43
LMNA P02545 1/20 0.43
CYP3A4 P08684 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6055739 0.91 GABRB3 (0.40) GABRB3GABRA2GABRB2GABRPGABRD
SCHEMBL6055913 0.89 GABRB3 (0.40) GABRB3GABRA2GABRB2GABRPGABRD
SCHEMBL6055825 0.88 GABRP (0.43) GABRB3GABRA2GABRB2GABRPGABRD
SCHEMBL6055782 0.86 GABRP (0.42) GABRB3GABRA2GABRB2GABRPGABRD
SCHEMBL7819222 0.85 GABRP (0.44) GABRB3GABRA2GABRB2GABRPGABRD
SCHEMBL7825819 0.85 GABRP (0.41) GABRB3GABRA2GABRB2GABRPGABRD
SCHEMBL7829679 0.84 GABRP (0.43) GABRB3GABRA2GABRB2GABRPGABRD
SCHEMBL4202646 0.84 GABRP (0.39) GABRB3GABRA2GABRB2GABRPGABRD
SCHEMBL6055897 0.84 GABRP (0.39) GABRB3GABRA2GABRB2GABRPGABRD
SCHEMBL6055895 0.83 GABRP (0.42) GABRB3GABRA2GABRB2GABRPGABRD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5236938-A Pesticidal 1-aryl-5-(substituted alkylideneimino)pyrazoles RHONE-POULENC INC. (US) 1993-08-17 US claimed
EP-0511845-A1 Pesticidal 1-aryl-5-(substituted alkylideneimino)-pyrazoles RHONE-POULENC AGROCHIMIE (FR) 1992-11-04 EP claimed
US-20060105969-A1 Anthelmintic compositions BRUCE CHRISTOPHER I 2006-05-18 US disclosed
EP-0511845-B1 Pesticidal 1-aryl-5-(substituted alkylideneimino)-pyrazoles AVENTIS CROPSCIENCE SA (FR) 2001-10-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060105969-A1 Anthelmintic compositions TUBB, TUBA3C, CYP51A1 GABRB3 2417/4885GABRA2 3701/4885GABRB2 2536/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.